ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

RESI Kelly Strategic ETF Trust Residential & Apt Real Estate ETF

16.23
0.00 (0.00%)
Last Updated: 20:00:00
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price
Ask Price
News -
Company Name Etf Ticker Symbol Market Type
Kelly Strategic ETF Trust Residential & Apt Real Estate ETF RESI NYSE Exchange Traded Fund
  Price Change Change Percent Etf Price Last Traded
0.00 0.00% 16.23 20:00:00
Open Price Low Price High Price Close Price Prev Close
16.23
Trades Volume Avg Volume
0 0 -
Last Trade Time Type Quantity Etf Price Currency
- 0  16.23 USD

Kelly Strategic ETF Trust Residential & Apt Real Estate ETF Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 811.50k - - - 15.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News Kelly Strategic

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No RESI Message Board. Create One! See More Posts on RESI Message Board See More Message Board Posts

RESI Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

The investment seeks to track the total return performance of the Strategic CRISPR & Gene Editing Technology Index. The adviser employs a ¿passive management¿ investment approach designed to track the total return performance of the index. The index is a rules-based index that consists of the stocks or corresponding depositary receipts of companies engaged in the creation, development, production, operation, provision, distribution, ownership, servicing, licensing, leasing or franchising of at least one of the DNA Modification Technology Business. The fund invests at least 80% of its net assets in DNA Modification Technology Companies. It is non-diversified.

Your Recent History

Delayed Upgrade Clock